R64C (p.Arg64Cys) variant of FBN2 (Fibrillin-2)

R64C (p.Arg64Cys) in FBN2 (Fibrillin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.41 / 1. The record also includes population frequency data and structural context.

R64C (p.Arg64Cys) variant details